Perez, EGF, Olivé, G, Chen, LW, Paredes-Carmona, F, Nuñez-Enamorado, N, Duran, SB, Mendibe, MD, Visa-Reñe, N, Vasquez-Lopez, M, Felipe-Rucián, A, Romeu, G, Martinez, E, Blanco, Y, Sepulveda, M, Saiz, A, Dalmau, J, Armangue, T. Clinical features of children with MOG-IgG who fulfill criteria of multiple sclerosis and overlapping disorders. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).

Cabrera-Maqueda, JM, Perez, EGF, Smith, CS, Chamorro, FJH, García, MA, Velilla, G, Gil-Perotin, SG, Martin-Aguilar, L, Velasco, R, Castillo-Triviño, T, Garcia, JLC, García, PC, García, CI, Cacabelos, PP, González-Suárez, I, Cladera, MM, de Larraya, JGP, Molina, EG, Iglesias, GT, Gallego, MD, Alcántara, LA, Guerra-Fernández, V, Alba, MT, Planagumà, J, Martinez-Cibrian, N, Martínez, E, Blanco, Y. Tocilizumab Did Not Increase the Risk of Severe ICANS in 600 patients treated with CD19 CAR-T Therapy. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).

Velasco, JIF, Jorge, FR, Monreal, E, Gracia, J, Díaz, EF, Meca-Lallana, V, Villarrubia, N, de la Maza, SS, Cortegana, EMP, Quiroga-Varela, A, Ramio-Torrentá, L, Martínez-Yélamos, S, Vila, LB, Real, AML, Romero, AR, Canelo, LB, Nicolas, SD, Eguia, P, Espiño, M, Garcia, JLC, Hernandez, FJB, González, JLV, Meca-Lallana, JE, Martos, PG, Gines, MLM, García-Dominguez, JM, Moreno, I, Sainz, R, Mañe, A, Rodriguez, ABC, Pinedo, FC, Labiano, A, Ayuso, L, Abreu, R, Hernández, MA, Rodríguez, MR, Martín-Aguilar, L, González, AH, Rojas, FJV, Cabredo, LF, Sanchez-Seco, VG, Muñoz, JS, Polo, LF, Castañon, IG, Moreno, SMG, Masjuan, J, Costa-Frossard, L, Guimerans, LMV. NfL and GFAP treatment-response serum biomarkers are influenced by elapsed time from MS onset to ocrelizumab initiation. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).

Batista, FD, Carcamo, PM, Nelson, E, Neto, ABD, Tsuha, DH, Lahdo, V, dos Santos, VR, Ribeiro, GS, Lopes, RD, Amadeu, P, Blanco, MVFM, da Costa, TR, Chalegre, KDD, Riback, TIS, da Silva, CC, Ranzani, OT, Cummings, DAT, Andrews, JR, Ko, AI, Hitchings, MDT, Anders, KL, Moreira, LA, Gonçalves, CCM, Croda, J. The impact of large-scale release of Wolbachia mosquitoes on dengue incidence in Campo Grande, Brazil: an ecological study. Lancet Regional Health-Americas. 2026; 54DOI:10.1016/j.lana.2025.101327. PMID:41438239. IF:(Q/D).

Ranzani, OT, Neto, FL, Mareto, LK, Brumatti, TS, Oliveira, RDD, Silva, PVD, Santos, ERD, Agostini, TLD, Paula, RACD, Dean, NE, Ko, A, Cummings, DAT, Andrews, JR, Hitchings, MDT, Croda, J. Effectiveness of theTAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: atest-negative, case-control study. LANCET INFECTIOUS DISEASES. 2026; 26(1)DOI:10.1016/S1473-3099(25)00382-2. PMID:40845862. IF:31.000(Q1/1D).

Ranzani, OT, Singer, M, Salluh, JIF, Shankar-Hari, M, Pilcher, D, Berger-Estilita, J, Coopersmith, CM, Juffermans, NP, Laffey, J, Reinikainen, M, Neto, AS, Tavares, M, Timsit, JF, Lopez, MDA, Arulkumaran, N, Aryal, D, Azoulay, E, Celi, LA, Chaudhuri, D, De Lange, D, De Waele, J, Dos Santos, CC, Du, B, Einav, S, Engelbrecht, T, Fazla, F, Ferrer, R, Finazzi, S, Fujii, T, Gershengorn, HB, Greene, JD, Haniffa, R, Hao, SC, Hasan, MS, Hollenberg, S, Ippolito, M, Jung, C, Kirov, M, Kobari, S, Lakbar, I, Lipman, J, Liu, V, Liu, XL, Lobo, SM, Magatti, D, Martin, GS, Metnitz, B, Metnitz, P, Myatra, SN, Oczkowski, S, Paiva, JA, Paruk, F, Pekkarinen, PT, Piquilloud, L, Pölkki, A, Prescott, HC, Blaser, AR, Rezende, E, Robba, C, Rochwerg, B, Ruckly, S, Samei, R, Schenck, EJ, Secombe, P, Sendagire, C, Siaw-Frimpong, M, Simpkin, AJ, Soares, M, Summers, C, Szczeklik, W, Takala, J, Tanaka, S, Tricella, G, Vincent, JL, Wendon, J, Zampieri, FG, Rhodes, A, Moreno, R. Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2025; 334(23)DOI:10.1001/jama.2025.20516. PMID:41159833. IF:55.000(Q1/1D).